COLORADO SPRINGS, Colo.,
Aug. 9, 2013 /PRNewswire/ -- The
X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing in cannabinoid formulation-based health and wellness
solutions, commends CNN's Dr. Sanjay
Gupta's reporting on the life saving medical cannabis
treatment of child with a severe seizure syndrome. CNN's coverage
is the inspiring life-saving story of a child with Dravet Syndrome,
also known as severe myoclonic epilepsy of infancy (SMEI), who
nearly died from 5 years of seizures and ineffective and damaging
conventional treatments.
After a year-long study of medical cannabis and first-hand
observation of patient outcomes, such as the seizure patient just
described, CNN's Dr. Gupta, a renowned neurosurgeon and medical
commentator, publicly announced in an editorial published yesterday
that he has reversed his position and now supports patient use of
medical cannabis.
"Why I Changed my Mind on Weed"
By Dr. Sanjay Gupta, CNN Chief
Medical Correspondent
August 9, 2013 -- Updated
0044 GMT (0844 HKT) :
http://edition.cnn.com/2013/08/08/health/gupta-changed-mind-marijuana/index.html
Dr. Gupta notes that "[we] have been terribly and systematically
misled [about medical cannabis] for nearly 70 years in the United States, and I apologize for my own
role in that," citing a contrary article Dr. Gupta wrote only four
years ago for Time magazine. Dr. Gupta continues in his
editorial: "... I didn't look hard enough, until now. I didn't look
far enough. I didn't review papers from smaller labs in other
countries doing some remarkable research, and I was too dismissive
of the loud chorus of legitimate patients whose symptoms improved
on cannabis."
The young child reached the point where she could no longer
talk, walk, or eat. With little hope of her survival, the
young girl's parents learned that medical cannabis might provide a
solution. Despite initial skepticism, under appropriate
physician care afforded by evolving laws, the parents and doctors
proceeded with treatment. As reported, the first dose of
cannabis oil immediately reduced the monthly incidence of their
daughter's grand mal seizures from more than 1,200 to 2 or 3.
Further, with a continuing regimen of medical cannabis oil
treatment, their daughter's mental and physiological damage has
abated, and she is regaining verbal skills, feeding herself, and
riding her bicycle.
Please visit:
http://www.cnn.com/2013/08/07/health/charlotte-child-medical-marijuana/index.html?hpt=hp_t1
Dr. Dorothy Bray, President of
The X-Change Corporation, said, "As increasing numbers of
researchers, physicians, and politicians line up behind the
effective, compassionate use of cannabinoid-based treatments, the
Company's research and commercial development programs continue to
move forward with confidence."
About The X-Change Corporation
The X-Change Corporation is currently developing new natural
cannabinoid containing products based on innovative formulations to
utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known
and applied for thousands of years. With the aid of scientific
research, The X-Change Corporation is translating such knowledge
into development of effective cannabinoid formulation-based health
and wellness solutions as well as cosmeceutical, nutraceutical, and
food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal
needs and will evolve with the introduction of new formulations and
products, advancing the Company within the expanding
multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Act of 1934. A statement containing works
such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
solutions. X-Change Corp. does not undertake any duty nor does it
intend to update the results of these forward-looking
statements.
The X-Change Corporation
Dr. Dorothy Bray, President
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595
Investment Inquiries
Robert Kane
CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824
SOURCE The X-Change Corporation